Phase II Study of Brivanib (BMS-582664) to Treat Multiple Tumor Types
about
Phase II Study of Brivanib (BMS-582664) to Treat Multiple Tumor Types
description
clinical trial
@en
klinisch onderzoek
@nl
name
Phase II Study of Brivanib (BMS-582664) to Treat Multiple Tumor Types
@en
type
label
Phase II Study of Brivanib (BMS-582664) to Treat Multiple Tumor Types
@en
prefLabel
Phase II Study of Brivanib (BMS-582664) to Treat Multiple Tumor Types
@en
P17
P6153
P1476
A Randomized Discontinuation S ...... Subjects With Advanced Tumors
@en
P3098
NCT00633789
P580
2008-06-01T00:00:00Z
P582
2012-02-01T00:00:00Z